Michael Mussallem, Chief Executive of the Irvine based heart valve making company Edwards Lifesciences Corp. has said that the firm is expecting a revenue growth of 10% in the year 2010.

Mussallem told the attendees at Reuters Health Summit in New York that, “Presently, we are tracking a growth rate above 10% and expect that it will continue to remain the same. We are hoping that Wall Street will not be disappointed with our performance”.

It is also true that the forecast is topping Wall Street’s view.

Analysts are expecting the revenue of Edwards to rise at $1.42 billion in the year 2010 that will be 8% up from a $1.31 billion revenue projection for the current year.

Earlier Edwards Lifesciences Corp. also said that it is expecting a full-year 2009 revenue between $1.30 billion to $1.35 billion.

Mussallem also said that the increasing demand for the company’s heart valves, critical-care products and heart surgery devices will increase the sales in the year 2010.

This entry was posted on Thursday, November 12th, 2009 at 3:08 pm and is filed under Venture Capital News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.